Home Tags Health Costs

Tag: Health Costs

Inaccuracies in provider directories are associated with use of out-of-network mental health care providers and surprise bills

Inaccurate Provider Directories Can Lead to Out-of-Network Mental Health Care

Inaccuracies associated with use of out-of-network providers, surprise bills
Reacting to skyrocketing prices for insulin

New Medicare Benefit Would Limit Insulin Copays to $35 a Month

Benefit will be voluntary; Medicare recipients must pick an insurance plan that provides it
Spending on inpatient services

Spending on Primary Care Continues to Lag in the U.S.

Authors say increasing investment in primary care could slow future health care spending growth
A prototype for a low-cost

Low-Cost, Noninvasive Ventilator Feasible for Breathing Support

Inspiratory/expiratory pressures up to 20/10 cmH20, respectively; no faulty triggering, cycling
Nonfatal injuries are costly

Average of 11 Work Days Lost Due to Injury Per Person in U.S.

Lost work days have an average value of $1,560, with variation by injury mechanism, body region
After insurer payment

Surprise Billing Found for Visits to Ambulatory Surgery Centers

One in 10 episodes resulted in charges for out-of-network ancillary providers at in-network facilities
A single symptomatic COVID-19 infection results in direct medical costs of $3

Direct Medical Costs of COVID-19 Infection Are Considerable

Costs could vary from $163.4 to $654.0 billion for 20 to 80 percent of U.S. population infected, respectively
A claims-based frailty index can improve current Medicare cost prediction for patients with different levels of frailty

Claims-Based Frailty Index Can Improve Cost Prediction

Addition of frailty index to CMS-HCC model improves cost prediction over CMS-HCC model alone
National health expenditures are projected to increase at an average annual rate of 5.4 percent for 2019 to 2028

National Health Spending Expected to Increase Through 2028

National health expenditures expected to represent 19.7 percent of gross domestic product by 2028
Use of tenofovir alafenamide-emtricitabine is not cost-effective compared with generic tenofovir disoproxil fumarate-emtricitabine for HIV preexposure prophylaxis among men who have sex with men

New HIV PrEP Drug Not Cost-Effective Compared With Generic

F/TAF would avert 2,101 fractures, 25 cases of end-stage renal disease, but not deemed cost-effective